MOSCOW, June 6 — RIA Novosti. the Ministry of health has registered another drug for the treatment COVID-19. As reported by press service agencies, registration card received the drug “Levelmap” (trade name of “Alcira”).
“the Drug is indicated for patients with severe disease develops when the so-called cytokine storm — an excessive inflammatory reaction to the introduction of the virus, which causes damage to tissues and organs, in particular lung tissue, to a severe course of the infection with a possible lethal outcome”, — stated in the message.
“Levelmap” produces biotechnological company Biocad. This is an original Patriotic inhibitor of interleukin-6.
As follows from the temporary methodical recommendations of the Ministry of health for the prevention, diagnosis and treatment coronavirus infection, the mortality rate is COVID-19 is associated with increased levels of interleukin-6. Initially the drug was developed for treatment of rheumatoid arthritis.
Pandemic coronavirus infection COVID-19 covered almost the whole world. According to the latest who data, there are over six and a half million infected, 387 thousand of them died.
In Russia, the number of cases of infection with coronavirus exceeded 458 thousand, more than 5.7 thousand people died, more than 220 thousand were cured.
